AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,587 | -12.6% | 751 | 0.0% | 0.00% | – |
| Q2 2023 | $21,268 | +193245.5% | 751 | +54.8% | 0.00% | – |
| Q1 2023 | $11 | -78.0% | 485 | -72.8% | 0.00% | – |
| Q4 2022 | $50 | -99.9% | 1,785 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | +25.6% | 1,785 | +2.6% | 0.00% | – |
| Q2 2022 | $39,000 | +200.0% | 1,740 | +295.5% | 0.00% | – |
| Q1 2022 | $13,000 | -75.5% | 440 | -74.3% | 0.00% | – |
| Q4 2021 | $53,000 | -59.5% | 1,710 | -39.6% | 0.00% | -100.0% |
| Q3 2021 | $131,000 | -16.0% | 2,830 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | +7.6% | 2,830 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $145,000 | +457.7% | 2,800 | +366.7% | 0.00% | – |
| Q4 2020 | $26,000 | -69.8% | 600 | -75.6% | 0.00% | -100.0% |
| Q3 2020 | $86,000 | +168.8% | 2,458 | +309.7% | 0.00% | – |
| Q2 2020 | $32,000 | +52.4% | 600 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | -90.2% | 600 | -87.1% | 0.00% | -100.0% |
| Q4 2018 | $214,000 | -40.2% | 4,642 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $358,000 | +4375.0% | 4,642 | +2221.0% | 0.00% | – |
| Q1 2016 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |